Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2001
03/15/2001CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery
03/15/2001CA2384046A1 Method for improving and maintaining bowel function as well as a method for the production thereof
03/15/2001CA2383996A1 Agent for stimulating bowel function and method for producing the same
03/15/2001CA2383971A1 Prophylactic and therapeutic medicaments for ophthalmic diseases
03/15/2001CA2383798A1 Pulmonary delivery for bioconjugation
03/15/2001CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents
03/15/2001CA2383782A1 Compounds for the treatment of viral infections
03/15/2001CA2383774A1 Fibroblast growth factor-like polypeptides
03/15/2001CA2383523A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
03/15/2001CA2348067A1 Composition for extending post meal satiety
03/15/2001CA2286408A1 The use of msm
03/14/2001EP1083232A1 Transfer of mRNA using polycationic compounds
03/14/2001EP1083196A1 Underwater granulation of therapeutic agent containing melts
03/14/2001EP1083184A2 Silicon-containing polymers, their preparation and their use
03/14/2001EP1082966A1 Anti-inflammatory eye drops
03/14/2001EP1082965A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
03/14/2001EP1082957A1 Effervescent granulate with delayed effervescence
03/14/2001EP1082911A2 Food using gamma-aminobutyric acid-enriched cruciferous plant
03/14/2001EP1082456A1 Antisense modulation of cd40 expression
03/14/2001EP1082313A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
03/14/2001EP1082293A2 Formoterol polymorphs
03/14/2001EP1082135A1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
03/14/2001EP1082132A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation
03/14/2001EP1082119A1 Microemulsion preconcentrates containing a piperidine substance p antagonist
03/14/2001EP1082117A1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
03/14/2001EP1082109A1 Oral formulation comprising biguanide and an organic acid
03/14/2001EP1082107A1 Controlled release lipoic acid
03/14/2001EP1082106A1 Sublingual buccal effervescent
03/14/2001EP1082105A1 Controlled drug delivery system using the conjugation of drug to biodegradable polyester
03/14/2001EP1082104A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them
03/14/2001EP1082103A1 Spill resistant pharmaceutical compositions
03/14/2001EP1082102A1 Biologically active composition
03/14/2001EP1082089A1 Devices with coatings containing chlorhexidine gluconate, compositions and methods
03/14/2001EP1082056A1 Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
03/14/2001EP1082029A1 Sitostanol formulation with emulsifier to reduce cholesterol absorption
03/14/2001EP1027085A4 Prepolymer compositions comprising an antimicrobial agent
03/14/2001EP1011767A4 Device for administering insulin in controlled dosages by controlling total inhaled volume
03/14/2001EP0980202A4 Methods for viral inactivation and compositions for use in same
03/14/2001EP0929297A4 Hollow bone mineral-like calcium phosphate particles
03/14/2001EP0810823B1 Composition for controlling parasites
03/14/2001EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/14/2001EP0707472B1 Method of controlling the size of liposomes
03/14/2001EP0701455B1 Plasma-like solution
03/14/2001EP0640143B1 Senescent cell derived inhibitors of dna synthesis
03/14/2001CN1287495A Powdery pernasal compositions
03/14/2001CN1287494A preventives / remedies for glaucoma
03/14/2001CN1287492A Method for administering ASPB 28-human insulin
03/14/2001CN1287491A Method for administering monomeric insulin analogs
03/14/2001CN1287490A Pharmaceutical composition having antitumor activity and process for the preparation thereof
03/14/2001CN1287486A Method and composition for delivering zinc to the nasal membrane
03/14/2001CN1287484A Therapeutic formulation for administering tolterodine with controlled release
03/14/2001CN1287127A Folica acid-polysaccharide composite and its preparation and medical composition with the composite as active component
03/14/2001CN1287007A Preparation of freeze-dried spirulina powder containing diabetes resisting factor
03/14/2001CN1287000A Chinese medicine ointment in gauze belt for treating burns and infectious trauma and its preparation process
03/14/2001CN1286998A Gastroenteritic disease treating medicine and its preparation
03/14/2001CN1286997A Antiphlogistic and analgesic ointment for treating rheumatism and trauma
03/14/2001CN1286996A Sucked Chinese medicine preparation for treating gastropathy
03/14/2001CN1286989A Suppository for treating cervical erosion and vaginitis
03/14/2001CN1286988A Nourishing health granule
03/14/2001CN1286980A Honey injecta and its preparation
03/14/2001CN1286977A Production process of xiaoliang cold capsule
03/14/2001CN1063088C Gandanzhi-Chinese herbal medicine for treating liver and gallbladder disorder
03/14/2001CN1063084C Puhuang pills
03/14/2001CN1063080C Ointment for curing onychomycosis and preparing process thereof
03/14/2001CN1063072C Tung oil plaster for reinforcing muscles and strengthening bones and its preparing method
03/14/2001CN1063061C Chinese herb medicine foot-bathing ointment good for lungs
03/14/2001CN1063060C Compound Chinese medicine preparation for curing traumatic paraplegia and its producing process
03/14/2001CN1063056C Oral liquid for relieving cancer pain of patient
03/14/2001CN1063053C Burns and scalds medicinal oil
03/14/2001CN1063047C Capsule using clam extract as main medicinal component and producing mehtod thereof
03/14/2001CN1063045C Foetus umbilical serum eyedrops and its application
03/14/2001CN1063043C Medical preparation for feet
03/14/2001CN1063024C 口香糖 Chewing gum
03/13/2001US6201072 Block copolymers of polyether and polyester
03/13/2001US6201065 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
03/13/2001US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction
03/13/2001US6201014 Unit dosage form of capsaisin or resiniferatoxin in admixture with a carrier for drug delivery to intestines to treat gastrointestinal disorders
03/13/2001US6201012 Composition for controlling parasites
03/13/2001US6201009 Absorption-enhancing composition for pantothenic acid derivative
03/13/2001US6200983 For treating erectile dysfunction in psychogenic male patients; time-release agents
03/13/2001US6200968 Particle-forming compositions containing fused pyrrolocarbazoles
03/13/2001US6200956 Nucleic acid-containing composition, preparation and use thereof
03/13/2001US6200605 Adminisering a composition of a polysaccharide and a preservative by means of a dietary supplement
03/13/2001US6200604 Sublingual buccal effervescent
03/13/2001US6200603 Comestible capsules having flavored coatings
03/13/2001US6200602 Mixture of polar drug and absorption promoter
03/13/2001US6200601 Softgel capsule containing Dha and antioxidants
03/13/2001US6200600 Controlled delay release device
03/13/2001US6200599 Ortho ester lipids
03/13/2001US6200598 Active materials entrapped within liposome interior
03/13/2001US6200597 Unit dosage form containing retinoid
03/13/2001US6200593 Contraceptive method employing buccal delivery of steroidal active agents
03/13/2001US6200591 High speed, accuarcy supplying through nose
03/13/2001US6200590 Controlled, phased-release suppository and its method of production
03/13/2001US6200589 Biological implants of semipermeable amphiphilic membranes
03/13/2001US6200569 Water extract or a dilute acidic extract of polygonum multiform roots or cinnamomum bark; decreasing the glycosylated hemoglobin level or blood glucose level in a hyperglycemic patient
03/13/2001US6200557 Activated stabilized chlorine dioxide and phosphates, such as disodium hydrogen phosphate, sodium dihydrogen phosphate, trisodium phosphate, and sodium monofluorophosphate
03/13/2001US6200549 Contains less than 0.0001% w/w surfactant based upon the weight of medicament
03/13/2001US6200548 Gas or air filled polymeric microballoons
03/13/2001US6200547 Carrier including particles that include iron and carbon; therapeutic amount of doxorubicin or paclitaxel adsorbed on the particles.